Brochures & Flyers
Celares - From Development to Production
celares GmbH has outstanding technical know-how in the fields of synthetix chemistry, biotechnology and bioanalytics wich is complemented by a high level of experitse and many years of experience in the areas of polymer materials, modified protein drugs and PEGylation.
PEGylation feasibility studies at celares GmbH
PEGylation is an established method for the delivery of biopharmaceuticals. The modification with polyethylene glycol (PEG) is capable of improving the pharmacological and physico-chemical properties of a drug significantly. Thus, PEGylation today is mandatory to think about when developing a biopharmaceutical drug.
Celares - scil proteins
Celares GmbH and Scil Proteins GmbH offer a one-stop-solution for supply and manufacturing of PEGylated Proteins
Customized PEGylation of Biopharmaceuticals
PEGylation is an established tool to increase potency, half-life and solubility of biopharmaceuticals. celares GmbH offers customized PEGylation services for the development of PEGylated drugs.
cGMP PEG for the PEGylation of peptides and proteins
At its location in Berlin-Buch, Germany, celares GmbH manufactures activated polyethylene glycol (PEG) according to cGMP for the use in PEGylation, an established tool to increase potency, half-life and solubility of biopharmaceuticals. Activated PEGs are key starting materials for the manufacturing of PEGylated drugs.
CelaSYS – Customized PEGylation Solutions BOS CMC Copenhagen 2012
Celares - CUSTOMIZED PEGYLATION SOLUTIONS